BOSTON SCIENTIFIC CORP (BSX) Form 8-K — Oct 7, 2026
Boston Scientific promoted Joseph M. Fitzgerald, EVP and Group President, Cardiovascular, to Executive Vice President and Chief Operating Officer effective January 1, 2027. Fitzgerald, a 1990 company joiner, will report to Chairman and CEO Mike Mahoney and oversee global operations, business units and regions. In connection with the appointment, the company will reorganize into three reportable segments — Interventional Therapies, Rhythm Solutions and MedSurg — effective January 1, 2027, designed to enable faster decision-making and strategic allocation of investments.
Key figures
- Coo base salary
- $1,050,000
- Coo bonus target
- 110% of base salary
- Coo 2027 equity award
- $7,000,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.